Tactical Combat Casualty Care (TCCC), Program Number 809

Abstract

The TCCC program provides lifesaving medical devices, ancillary equipment and Casualty Evacuation (CASEVAC) sets for SOF. The CASEVAC procures a suite of Food and Drug Administration (FDA) approved medical items including, but not limited to, intraosseous infusion devices, patient monitoring and assessment devices, emergency airway kits, as well as devices that provide SOF the capability to support extraction, mobility, transportation, and sustainment of casualties in forward areas. The TCCC program fields essential lifesaving CASEVAC equipment and capabilities and is a platform to transition capabilities developed under the National Mission Force's Tactical Medical Programs. This campaigning capability, aligning to the 2022 National Defense Strategy, provides significant ability to counter competitor coercion and lessen battlefield losses by providing timely, critical lifesaving and evacuation capabilities to the forward-deployed SOF operators.

Document Details

Document Type
Accomplishment
Publication Date
Oct 01, 2024
Source ID
5a87fc3ee43548021f0986142be5a446

Tags

Readers

  • Trauma or Military Medicine
  • Unmanned Aerial System (UAS) Autonomous Capabilities and Mission Reconnaissance.

Related Documents